Brain Scientists Are Tripping Out Over Psychedelics

Brain Scientists Are Tripping Out Over Psychedelics

  • Forfatter
  • Afsnit
    • 809
  • Udgivet
    • 21. dec. 2022
  • Forlag
0 Anmeldelser
0
Afsnit
809 of 1563
Længde
11M
Sprog
Engelsk
Format
Kategori
Fakta

Psychedelic drugs – like LSD, salvia, ayahuasca, Ibogaine, MDMA (AKA ecstasy), or psilocybin (AKA 'magic mushrooms' or 'shrooms') – are experiencing a resurgence of interest in their potential medical benefits.

At the Neuroscience 2022 meeting held by the Society of Neuroscience, the appetite for psychedelic research permeated the sessions, discussions, and even after-hours barroom talk — drawing in researchers, neuroscientists, companies, reporters, and advocates alike.

"In the last couple of years there has been a lot of excitement in psychedelics. I think it started first in the popular media." says Alex Kwan, associate professor at Cornell University. "Neuroscience, actually, I think took another year or two to catch on." Today on the show, host Aaron Scott and NPR's brain correspondent Jon Hamilton chat psychedelic drugs — whether this renewed interest will represent incremental or revolutionary changes in the fields of medicine, psychology, and neuroscience.

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

NPR Privacy Policy


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
Cover for Brain Scientists Are Tripping Out Over Psychedelics

Other podcasts you might like ...